Tauns Laboratories Inc
197A
Company Profile
Business description
Tauns Laboratories Inc is engaged in development, manufacture and sales of in vitro diagnostics and research reagents and its intermediates in Japan and internationally. The company also offers medical physicochemical measuring equipment, industrial measuring equipment, and medical devices; and contract research services. Its product include Capilia Flu Neo, Capilia Adeno Neo, Capilia, RSV Neo, Capilia hMPV, etc.
Contact
761-1 Kamishima Izunokuni-shi
Shizuoka410-2325
JPNT: +81 558768181
Sector
Healthcare
Stock type
Defensive
Industry
Medical Instruments & Supplies
Fiscal Year End
30 June 2027
Employees
446
Stocks News & Analysis
stocks
ASX major bank drives strong quarterly profit
Profit momentum remains robust yet shares overvalued.
stocks
Ask the analyst: What to expect in earnings season?
The key metrics that matter this earnings season.
stocks
ASX healthcare share remains undervalued ahead of earnings
Margin recovery remains the key driver for this ASX healthcare share.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,063.80 | 36.20 | 0.40% |
| CAC 40 | 8,406.06 | 33.78 | 0.40% |
| DAX 40 | 25,361.03 | 262.03 | 1.04% |
| Dow JONES (US) | 52,027.86 | 80.61 | 0.16% |
| FTSE 100 | 10,781.75 | 45.52 | 0.42% |
| HKSE | 25,207.18 | 243.95 | 0.98% |
| NASDAQ | 24,832.46 | 143.37 | -0.57% |
| Nikkei 225 | 64,931.19 | 320.04 | 0.50% |
| NZX 50 Index | 13,850.69 | 78.40 | 0.57% |
| S&P 500 | 7,390.13 | 21.85 | -0.29% |
| S&P/ASX 200 | 8,894.00 | 36.10 | 0.41% |
| SSE Composite Index | 3,858.25 | 44.05 | 1.15% |